Evidence map›Paper›PMID 40727375›Full record

ArticleQuantitative imaging in medicine and surgery2025

Analyzing explainability of YOLO-based breast cancer detection using heat map visualizations.

Awika Ariyametkul, May Phu Paing

Abstract read
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Benchmarking YOLOs in breast ultrasound lesion segmentation.Quantitative imaging in medicine and surgery · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Awika AriyametkulDepartment of Biomedical Engineering, School of Engineering, King Mongkut's Institute of Technology Ladkrabang, Bangkok, Thailand.
May Phu PaingDepartment of Biomedical Engineering, School of Engineering, King Mongkut's Institute of Technology Ladkrabang, Bangkok, Thailand.ORCID https://orcid.org/0000-0002-5071-1535

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Breast cancer is the most frequently diagnosed and leading cause of cancer-related mortality among women worldwide. The danger of this disease is due to its asymptomatic nature in the early stages, thereby underscoring the importance of early detection. Mammography, a specialized X-ray imaging technique for breast examination, has been pivotal in facilitating early detection and reducing mortality rates. In recent years, artificial intelligence (AI) has gained substantial popularity across various fields, including medicine. Numerous studies have leveraged AI techniques, particularly convolutional neural networks (CNNs) and You Only Look Once (YOLO)-based models, for medical image detection and classification. However, the predictions of such AI models often lack transparency and explainability, resulting in low trustworthiness. This study aims to address this gap by investigating three state-of-the-art versions of the YOLO algorithm-YOLO version 9 (YOLOv9), YOLO version 10 (YOLOv10), and YOLO version 11 (YOLO11)-trained on breast cancer imaging datasets, specifically the INbreast and Mammographic Image Analysis Society (MIAS) databases. Additionally, to address the challenges posed by the lack of explainability and transparency, we integrate seven explainable artificial intelligence (XAI) methods: Grad-CAM, Grad-CAM++, Eigen-CAM, EigenGrad-CAM, XGrad-CAM, LayerCAM, and HiResCAM. Methods: This study utilized two publicly available breast cancer image databases: INbreast: toward a Full-field Digital Mammographic Database and the MIAS dataset. Preprocessing steps were applied to standardize all images in accordance with the input requirements of the YOLO architecture, as these datasets were used to train the three most recent versions of YOLO. The YOLO model demonstrating the highest performance-measured by mean average precision (mAP), precision, and recall-was selected for integration with seven different XAI methods. The performance of each XAI technique was evaluated both qualitatively through visual inspection and quantitatively using several metrics, including matching ground truth (mGT), Pearson correlation coefficient (PCC), precision, recall, and root mean square error (RMSE). These methodologies were employed to interpret and visualize the "black box" decision-making processes of the top-performing YOLO model. Results: Based on our experimental findings, YOLO11 outperformed YOLOv9 (mAP 0.868) and YOLOv10 (mAP 0.926), achieving the highest mAP of 0.935, with classification accuracies of 95% for benign and 80% for malignant cases. Among the evaluated XAI techniques, HiResCAM provided the most effective visual explanations, attaining the highest mGT score of 0.49, surpassing EigenGrad-CAM (0.45) and LayerCAM (0.42) in both visual and quantitative evaluations. Conclusions: The integration of YOLO11 with HiResCAM offers a robust solution that combines high detection accuracy with improved model interpretability. This approach not only enhances user trustworthiness by revealing decision-making patterns and limitations but also provide insights into the weaknesses of the model, enabling developers to refine and improve AI performance further.

Indexed as

Breast cancerexplainable artificial intelligence (XAI)You Only Look Once (YOLO)

Identifiers

PMID40727375
PMCPMC12290753

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.